Pharma Industry News

Q&A: Why the NIH is spending $30 million to counter ableism in health care

A new NIH program will allocate nearly $30 million to 10 groups over five years to examine the impact of ableism on various health outcomes for people with disabilities and to develop strategies to combat these disparities.

The studies investigate ableism towards several different populations, including people with low vision trying to access services and maternal health outcomes among Medicaid beneficiaries with intellectual and developmental disabilities.
Read the rest…

A new NIH program will allocate nearly $30 million to 10 groups over five years to examine the impact of ableism on various health outcomes for people with disabilities and to develop strategies to combat these disparities.

The studies investigate ableism towards several different populations, including people with low vision trying to access services and maternal health outcomes among Medicaid beneficiaries with intellectual and developmental disabilities.

Read the rest…

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]